The statements below are read from ONYX BIOTEC LIMITED’s filed results, 4 filed quarters and 5 fiscal years on record, standalone basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: H2 FY25-26 · filed Jul 18, 2026 · audited
This company files half-yearly statements with the exchange — each column is a six-month period; discrete quarterly figures are not published.
| ₹ Cr | H1 FY25Sep 2024 | H2 FY25Mar 2025 | H1 FY26Sep 2025 | H2 FY26Mar 2026Latest | YoYlatest |
|---|---|---|---|---|---|
| Sales | 30.1 | 31.8 | 34.6 | 34.9 | +9.7% |
| 24.4 | 27.2 | 33.6 | 32.4 | +19.4% | |
| Operating profit | 5.71 | 4.63 | 0.94 | 2.45 | -47.0% |
| OPM % | 18.9% | 14.6% | 2.7% | 7.0% | -7.5 pp |
| Other income | 0.99 | 0.18 | 0.24 | 0.21 | +14.5% |
| Interest | 1.36 | 0.62 | 0.55 | 0.66 | +6.1% |
| Depreciation | 1.53 | 1.51 | 1.56 | 1.49 | -1.4% |
| Profit before tax | 3.80 | 2.67 | -0.93 | 0.50 | -81.1% |
| Tax % | 21.5% | 26.4% | n/a (loss) | -35.9% | -62.3 pp |
| Net profit | 2.99 | 1.97 | -0.90 | 0.69 | -65.2% |
| EPS (₹) | 2.24 | 1.31 | -0.50 | 0.38 | -71.0% |
No results filing with a recorded time yet — reactions appear from the first quarter whose announcement we timestamped (May 2026 onward), on the session the market could trade it.
